News from decision resources

( EuronextParis:BND)

10:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing

Decision Resources Group finds that breakthrough therapy designation is likely to positively influence perceptions of emerging drugs for both...

Jul 10, 2014, 15:11 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Shifts In Healthcare Coverage For Millions Of American Lives Create Unique Data Challenge For Next Year Planning

 Decision Resources Group expects American lives to continue their vast migration to coverage, as post-ACA implementation coincides with a...

Jul 10, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis

Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval...

Jul 10, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT)

 Decision Resources Group finds that while more than three-quarters of surveyed infectious disease (ID) specialists are willing to prescribe...

Jul 09, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Asia Pacific Interventional Cardiology Device Market Will Continue to Grow Strongly Through 2022, Especially in China and India

 Decision Resources Group finds that the market for interventional cardiology (IC) devices still holds considerable potential for growth in the...

Jul 09, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Decision Resources Group Announces Enhanced Medical Device Market Coverage with Analysis of U.S. Hospital Purchasing Records and SKU-Level Data Visualized in Tableau

 Decision Resources Group announces the launch of PriceTrack, which is an extension of its premier medical technology market intelligence...

Jul 08, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Asia Pacific Transcatheter Embolization and Occlusion Device Market Will Be Driven By the Adoption of Flow-Diverting Devices and Radioembolization Spheres

 Decision Resources Group finds that the Asia Pacific market for transcatheter embolization and occlusion (TEO) devices—including...

Jul 08, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Latin American Trauma Device and Reconstructive Joint Implant Market Will Grow to $1.75 Billion by 2022

Decision Resources Group finds that the market for trauma devices and reconstructive joint implants in Argentina, Brazil, Colombia and Mexico will...

Jul 07, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Growing Concern over the Efficacy of Vancomycin is Prompting Greater Use of Branded Therapies for the Treatment of MRSA Infections

 Decision Resources Group finds that, although vancomycin continues to be the standard-of-care for infections caused by methicillin-resistant...

Jul 07, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Novo Nordisk's Insulin Degludec/Liraglutide is Set to Become the Clinical Gold-Standard Among Fixed-Dose Combination Therapies for Type 2 Diabetes

 Decision Resources Group finds that Novo Nordisk's fixed-dose combination (FDC) therapy insulin degludec/liraglutide (Xultophy, formerly known...

Jul 02, 2014, 13:45 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Medicaid Expansion "Dominoes" Continue To Fall As More States Enact And Submit Waivers

 Decision Resources Group expects most states to move toward Medicaid expansion in the next few years. Two key factors continue to drive the...

Jul 02, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Despite an Initial Decline in the European Market, the North American and European Dental Implant Markets Will Grow to Reach a Combined Value of $4.2 Billion by 2022

 Decision Resources Group finds that the North American and European markets for dental implants will expand through 2022 to reach a combined...

Jul 02, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Affordable Care Act Driving Significant Change in Indianapolis Market, Including the Dissolution of the Indiana Accountable Care Consortium

 Decision Resources Group finds that the Indianapolis market is in significant flux as it implements several key initiatives of the Affordable...

Jul 01, 2014, 14:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

In China, Surveyed Nephrologists Report Significant Declines in the Use of ESAs in Stage 3, 4 and 5 Chronic Kidney Disease Non-Dialysis Patient Populations, Compared with 2011

 Decision Resources Group finds that patient chart data submitted by surveyed nephrologists in China reveals that, consistent with 2011, the...

Jul 01, 2014, 10:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Chinese Facial Injectable Market Will Grow Nearly 20 Percent Annually Through 2022

 Decision Resources Group finds that the Chinese market for facial injectables, including hyaluronic acid (HA) dermal fillers and botulinum...

Jun 30, 2014, 11:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Cancer Immunotherapy Market Will Increase to Nearly $9 Billion Across the World's Major Pharmaceutical Markets In 2022

 Decision Resources Group finds that the immunotherapy market will experience considerable growth through 2022, increasing from $1.1 billion in...

Jun 26, 2014, 11:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

EU5 Payers are Looking for Superior Clinical Efficacy for COPD, in Light of the Launch of Novartis's Ultibro, the First LABA/LAMA Fixed-Dose Combination in Europe

 Decision Resources Group finds that surveyed pulmonologists in the EU5 (France, Germany, Italy, Spain and the United Kingdom) estimate that...

Jun 24, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Global Dental CAD/CAM System Market Will See Strong Growth to Reach a Value of Over $760 Million in 2022

Decision Resources Group finds that high cost and low awareness of dental computer-aided design/computer-aided manufacturing (CAD/CAM) systems have...

Jun 23, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed U.S. Psychiatrists Would Prescribe Otsuka/Lundbeck's Brexpiprazole to 12 Percent of Their Treatment-Resistant Depression Patients

 Decision Resources Group finds that surveyed U.S. psychiatrists are receptive to novel adjunctive therapies to antidepressants for...

Jun 19, 2014, 13:36 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Nearly Three-Quarters of Surveyed Primary Care Physicians are Unfamiliar with Approved Direct Acting Antivirals for Hepatitis C Virus

 Decision Resources Group finds that less than one-third of surveyed primary care physicians (PCPs) are familiar with the first-generation...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
Investor-Edge